Kanglaite Reduce the Toxicity of Radiotherapy of Head and Neck Cancer Phase II Study

Conditions:   Head and Neck Cancer;   Radiotherapy
Intervention:   Drug: Kanglaite Injection
Sponsor:   First Affiliated Hospital of Harbin Medical University
Recruiting - verified January 2017

http://ift.tt/2o3M2Ax